Delcath Systems
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DCTH and other ETFs, options, and stocks.About DCTH
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO.
CEOGerard J. Michel
CEOGerard J. Michel
Employees96
Employees96
HeadquartersQueensbury, New York
HeadquartersQueensbury, New York
Founded1988
Founded1988
Employees96
Employees96
DCTH Key Statistics
Market cap595.18M
Market cap595.18M
Price-Earnings ratio-33.80
Price-Earnings ratio-33.80
Dividend yield—
Dividend yield—
Average volume636.74K
Average volume636.74K
High today$17.15
High today$17.15
Low today$15.98
Low today$15.98
Open price$16.06
Open price$16.06
Volume539.30K
Volume539.30K
52 Week high$17.15
52 Week high$17.15
52 Week low$6.33
52 Week low$6.33
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own DCTH. This list is generated using Robinhood data, and it’s not a recommendation.